传GE Healthcare(GEHC.US)考虑出售中国业务估值或达数十亿美元

智通财经2025-09-18

智通财经APP获悉，知情人士称，GE Healthcare Technologies(GEHC.US)正在探索包括出售其中国子公司股份在内的多种选择。知情人士表示，这家美国医疗科技公司一直在与顾问合作，评估该业务的前景。知情人士表示，潜在的交易可能使这些中国资产的估值达到数十亿美元，这些考虑还处于初步阶段，尚未就任何潜在处置的时间和规模做出最终决定。在中国国内企业激烈竞争的背景下，除了GE ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2568474002?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-18 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2568474002","market":"fut","top_or_hot":-1,"title":"传GE Healthcare(GEHC.US)考虑出售中国业务 估值或达数十亿美元","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，知情人士称，GE Healthcare Technologies(GEHC.US)正在探索包括出售其中国子公司股份在内的多种选择。知情人士表示，这家美国医疗科技公司一直在与顾问合作，评估该业务的前景。知情人士表示，潜在的交易可能使这些中国资产的估值达到数十亿美元，这些考虑还处于初步阶段，尚未就任何潜在处置的时间和规模做出最终决定。在中国国内企业激烈竞争的背景下，除了GE ...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1346948.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>传GE Healthcare(GEHC.US)考虑出售中国业务 估值或达数十亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n传GE Healthcare(GEHC.US)考虑出售中国业务 估值或达数十亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-18 20:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1346948.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，知情人士称，GE Healthcare Technologies(GEHC.US)正在探索包括出售其中国子公司股份在内的多种选择。知情人士表示，这家美国医疗科技公司一直在与顾问合作，评估该业务的前景。知情人士表示，潜在的交易可能使这些中国资产的估值达到数十亿美元，这些考虑还处于初步阶段，尚未就任何潜在处置的时间和规模做出最终决定。在中国国内企业激烈竞争的背景下，除了GE ...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1346948.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1366192091.USD","symbol_name":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1346948.html","article_id":"2568474002","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2568474002","pubTimestamp":1758197158,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，知情人士称，GE Healthcare Technologies正在探索包括出售其中国子公司股份在内的多种选择。在中国国内企业激烈竞争的背景下，除了GE Healthcare，其他跨国公司也正在评估其在华业务的出售选项。GE Healthcare股价今年已下跌 2%，公司估值约为 350 亿美元。GE Healthcare产品包括影像扫描、超声波、患者护理解决方案和药物成像剂。GE Healthcare公布，2024年中国市场收入为24亿美元，较上年下降15%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","BK4585":"ETF&股票定投概念","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU2756315664.SGD":"ALLIANZ INCOME AND GROWTH \"AMI\" (SGDHDG) INC","LU0149725797.USD":"汇丰美国股市经济规模基金","LU2168564495.EUR":"AZ ALLOCATION - TREND \"AI\" (EUR) ACC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU2168564222.USD":"AZ ALLOCATION - TREND \"AAZ\" (USDHDG) ACC","LU0689626769.HKD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (HKD) ACC","BK4566":"资本集团","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU2168564065.EUR":"AZ ALLOCATION - TREND \"AAZ\" (EUR) ACC","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","BK4206":"工业集团企业","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","BK4082":"医疗保健设备","XLV":"健康照护类股ETF-SPDR","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU2168563687.JPY":"AZ ALLOCATION - TREND \"AAZ\" (JPYHDG) ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU2168564149.EUR":"AZ ALLOCATION - TREND \"BAZ\" (EUR) ACC","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","GEHC":"GE HEALTHCARE TECHNOLOGIES INC","BK4588":"碎股","XBI":"SPDR S&P Biotech ETF","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU1366333091.USD":"FIDELITY GLOBAL FOCUS \"A\" (USD) ACC","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","GE":"GE航空航天","BK4581":"高盛持仓","BK4187":"航天航空与国防","LU0157215616.USD":"FIDELITY GLOBAL FOCUS \"A\" INC","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","BK4543":"AI","BK4501":"段永平概念","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC"},"translate_title":"GE Healthcare (GEHC.US) is rumored to be considering selling its Chinese business with a valuation of billions of dollars","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GEHC":1.5,"XBI":0.6,"XLV":1.5,"GE":1.5},"content_text":"智通财经APP获悉，知情人士称，GE Healthcare Technologies(GEHC.US)正在探索包括出售其中国子公司股份在内的多种选择。知情人士表示，这家美国医疗科技公司一直在与顾问合作，评估该业务的前景。知情人士表示，潜在的交易可能使这些中国资产的估值达到数十亿美元，这些考虑还处于初步阶段，尚未就任何潜在处置的时间和规模做出最终决定。在中国国内企业激烈竞争的背景下，除了GE Healthcare，其他跨国公司也正在评估其在华业务的出售选项。国内本土企业已发展成为资深的竞争对手，与本地消费者建立了深厚的联系。其他正在考虑退出中国业务或某些本地资产的公司包括星巴克(SBUX.US)、通用磨坊(GIS.US)旗下的哈根达斯、迪卡侬以及餐饮品牌国际(QSR.US)旗下汉堡王。通用电气公司于 2023 年剥离了其医疗设备业务。GE Healthcare股价今年已下跌 2%，公司估值约为 350 亿美元。GE Healthcare产品包括影像扫描、超声波、患者护理解决方案和药物成像剂。根据其最新年度报告，中国是其第二大市场，拥有约7000名员工。GE Healthcare公布，2024年中国市场收入为24亿美元，较上年下降15%。截至6月的三个月，该公司报告中国市场收入再次下降3%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2568474002","isCrawlerRequest":true}

传GE Healthcare(GEHC.US)考虑出售中国业务 估值或达数十亿美元

精彩评论

传GE Healthcare(GEHC.US)考虑出售中国业务估值或达数十亿美元